290 results on '"Halfmann, Peter J."'
Search Results
2. A compendium of multi-omics data illuminating host responses to lethal human virus infections
3. Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters
4. Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine
5. Persistent SARS-CoV-2 infection: significance and implications
6. Defining the risk of SARS-CoV-2 variants on immune protection
7. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
8. Hypergraph Models of Biological Networks to Identify Genes Critical to Pathogenic Viral Response
9. Transmission and re-infection of Omicron variant XBB.1.5 in hamsters
10. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
11. Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2
12. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
13. Characterization of a new SARS-CoV-2 variant that emerged in Brazil
14. Cow’s Milk Containing Avian Influenza A(H5N1) Virus — Heat Inactivation and Infectivity in Mice
15. Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays
16. mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2
17. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
18. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
19. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
20. Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains
21. Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
22. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
23. Protective Immunity and Persistent Lung Sequelae in Domestic Cats after SARS-CoV-2 Infection
24. Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection
25. Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine
26. Mapping SARS-CoV-2 antigenic relationships and serological responses
27. Plasma lipidome reveals critical illness and recovery from human Ebola virus disease
28. Hypergraph models of biological networks to identify genes critical to pathogenic viral response
29. Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization
30. Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection.
31. Ebola Virus Infection Induces HCAR2 Expression Leading to Cell Death
32. An antiviral role for TRIM14 in Ebola virus infection
33. Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spread
34. Sensitivity of rapid antigen tests for Omicron subvariants of SARS‐CoV‐2
35. Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate
36. Replicative capacity of SARS-CoV-2 omicron variants BA.5 and BQ.1.1 at elevated temperatures
37. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
38. Identification of interferon-stimulated genes that attenuate Ebola virus infection
39. The Mucin-Like Domain of the Ebola Glycoprotein Does Not Impact Virulence or Pathogenicity in Ferrets.
40. Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB
41. Coronavirus Immunotherapeutic Consortium Database
42. Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual.
43. Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters
44. Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses
45. Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual
46. Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody to antigenically distinct omicron SARS-CoV-2 subvariants
47. Shedding of infectious SARS-CoV-2 despite vaccination
48. Host network-based discovery of critical regulators of innate immunity, virus growth, and pathogenesis in influenza virus infection
49. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
50. Characterization of the SARS-CoV-2 B.1.621 (Mu) variant
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.